Physician profile
Daniel Ricketti
NPI 1538653548
$17,597.44
in general payments reported to CMS, 2019-2025
11 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $258 · 2023: $169 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Food and Beverage: $1,985 · Travel and Lodging: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $14,000.00 |
| Food and Beverage | $1,984.94 |
| Travel and Lodging | $1,354.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,107.66 | 2025 | Emblem Mri S-Icd, General - Therapies, Rhythmia Mapping System |
| Medtronic, INC. | $5,000.00 | 2025 | |
| Abbott Laboratories | $4,000.00 | 2025 | Assurity, Tacticath |
| Actelion Pharmaceuticals US, INC. | $128.61 | 2023 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $123.11 | 2022 | |
| Atricure, INC. | $117.95 | 2022 | |
| Cordis US Corp. | $33.64 | 2025 | Mynx Control Venous |
| Biosense Webster, INC. | $29.55 | 2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.38 | 2023 | Lifevest |
| Chiesi USA, INC. | $17.00 | 2022 | |
| Philips North America LLC | $16.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ricketti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.